首页> 外文OA文献 >Biodegradable microcontainers as an oral drug delivery system for poorly soluble drugs.
【2h】

Biodegradable microcontainers as an oral drug delivery system for poorly soluble drugs.

机译:可生物降解的微容器作为难溶性药物的口服给药系统。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PURPOSE: To fabricate microcontainers in biodegradable polylactic acid (PLLA) polymer films using hot embossing, and investigate the application of fabricated microcontainers as an oral drug delivery system for a poorly soluble drug.METHODS: For fabrication of the PLLA microcontainers, a film of PLLA was produced by spin coating. The film was heated above the polymer glass transition temperature (Tg), and a stamp was forced into the film. Following cooling of the film the stamp was removed, exposing the formed microcontainers. Microcontainers were filled with amorphous furosemide sodium salt (produced by spray drying) using a simplified version of a screen printing technique. An enteric-resistant lid of Eudragit L-100 was subsequently spray coated onto the cavity of the microcontainers. Release of amorphous furosemide salt from the coated microcontainers was investigated using a μ-Diss profiler. Release experiments were carried out in biorelevant gastric medium (pH 1.6) for 2 h, followed by 3 h in a biorelevant intestinal medium (pH 6.5). Moreover, biorelevant flow through dissolution was also carried out in conjunction with UV imaging to visualize the release of amorphous furosemide salt from the coated microcontainers.RESULTS: Fabricated PLLA microcontainers had an inner diameter of 220 μm and a height of 100 μm. The screen printing technique was shown to be an optimized set-up to fill the microcontainers with drug. From the release experiments it was observed that the Eudragit layer prevented drug release in biorelevant gastric medium, while an immediate release of the amorphous furosemide salt was seen in the biorelevant intestinal medium. The same trend was observed in the UV imaging experiments –negligible drug release was observed in gastric medium, whereas following re-equilibration of the dissolution cell with the intestinal medium, a release of furosemide was observed after 1 min with an increased release after 5 min of dissolution.CONCLUSIONS: Biodegradable microcontainers were successfully fabricated and loaded with drug. Coating with Eudragit L-100 proved to be useful for protecting drug release from microcontainers in gastric medium, and facilitated an immediate release in the intestinal medium. The fabricated microcontainers therefore show considerable future potential as oral drug delivery systems.
机译:目的:利用热压花技术在可生物降解的聚乳酸(PLLA)聚合物薄膜中制造微容器,并研究已制成的微容器作为难溶性药物的口服药物递送系统的方法。通过旋涂生产。将膜加热到高于聚合物玻璃化转变温度(Tg),并将压模压入膜中。膜冷却后,除去压模,使形成的微容器暴露。使用简化版的丝网印刷技术,在微容器中填充无定形速尿钠盐(通过喷雾干燥生产)。随后将Eudragit L-100的抗肠溶性盖子喷涂到微容器的空腔上。使用μ-Diss轮廓分析仪研究了无定形呋塞米盐从包被的微容器中的释放。在与生物相关的胃介质(pH 1.6)中进行释放实验2 h,然后在与生物相关的肠介质(pH 6.5)中进行3 h。此外,还通过与溶出相关的生物相关流动与紫外线成像相结合,以可视化从包被的微容器中释放出无定形速尿盐。结果:制成的PLLA微容器的内径为220μm,高度为100μm。丝网印刷技术被证明是一种使微容器充满药物的优化设置。从释放实验中观察到,Eudragit层阻止了药物在与生物相关的胃介质中的释放,而在与生物有关的肠介质中看到了非晶态呋塞米盐的立即释放。在紫外线成像实验中观察到了相同的趋势–在胃介质中观察到的药物释放可忽略不计,而在通过肠道介质重新溶解细胞后,在1分钟后观察到速尿释放,在5分钟后释放增加结论:成功地制备了可生物降解的微容器并装载了药物。事实证明,用Eudragit L-100包衣可用于保护药物从胃容器中的微容器释放,并有助于在肠道介质中立即释放。因此,制造的微容器作为口服药物递送系统显示出巨大的未来潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号